DIVIS LABORATORIES
Back to Balance Sheet
|
DIVIS LABORATORIES Last 5 Year Profit & Loss Account Balance History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Profit & Loss Account Balance | ₹15,370 Cr | ₹13,400 Cr | ₹11,786 Cr | ₹10,959 Cr | ₹9,989 Cr |
What is the latest Profit & Loss Account Balance ratio of DIVIS LABORATORIES ?
| Year | Profit & Loss Account Balance |
|---|---|
| Mar2026 | ₹15,370 Cr |
| Mar2025 | ₹13,400 Cr |
| Mar2024 | ₹11,786 Cr |
| Mar2023 | ₹10,959 Cr |
| Mar2022 | ₹9,989 Cr |
How is Profit & Loss Account Balance of DIVIS LABORATORIES Trending?
| Years | Profit & Loss Account Balance | % Change | |
|---|---|---|---|
| Mar2026 | ₹15,370 Cr | 14.70 | |
| Mar2025 | ₹13,400 Cr | 13.69 | |
| Mar2024 | ₹11,786 Cr | 7.55 | |
| Mar2023 | ₹10,959 Cr | 9.71 | |
| Mar2022 | ₹9,989 Cr | - | |
Compare Profit & Loss Account Balance of peers of DIVIS LABORATORIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| DIVIS LABORATORIES | ₹246,766.3 Cr | -3.3% | 1.4% | 57.4% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹434,280.0 Cr | -2.4% | -6.2% | 11.8% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹181,129.0 Cr | -4.5% | -4% | 35.9% | Stock Analytics | |
| CIPLA | ₹108,808.0 Cr | -3.6% | -5% | -10.6% | Stock Analytics | |
| MANKIND PHARMA | ₹104,376.0 Cr | 2.1% | 7.1% | -0.6% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹100,170.0 Cr | -0.2% | 2.5% | -3% | Stock Analytics | |
DIVIS LABORATORIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| DIVIS LABORATORIES | -3.3% |
1.4% |
57.4% |
| SENSEX | -2.3% |
-6.6% |
-12% |
You may also like the below Video Courses